Skip to main content
SpringerLink
Log in

Autonomic Neuropathy and Heart Disease

  • Chapter
Clinical Management of Diabetic Neuropathy

Part of the book series: Contemporary Endocrinology ((COE,volume 7))

Abstract

Diabetes mellitus is associated with a high incidence of cardiovascular complications and has been identified as an independent risk factor for the development of coronary artery disease (1,2). Once the diagnosis of coronary disease is established, patients with diabetes have higher complication rates and higher mortality than their nondiabetic counterparts (3,4). Overall, diabetes increases the relative risk of cardiovascular death threefold in males regardless of the presence of other traditional risk factors, with an even more pronounced effect in diabetic females (5,6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035–2038.

    Article  PubMed  CAS  Google Scholar 

  2. Kannel WB, McGee D. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8–13.

    Article  PubMed  CAS  Google Scholar 

  3. Granger C, Califf R, Young S, et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol 1993;21:920.

    Article  PubMed  CAS  Google Scholar 

  4. Mueller H, Cohen L, Braunwald E, and the TIMI investigators. Predictors of early morbidity and mortality after thrombolytic therapy for acute myocardial infarction. Circulation 1992;85:1254.

    Article  PubMed  CAS  Google Scholar 

  5. Stamler J, Vaccaro O, Neaton J, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–444.

    Article  PubMed  CAS  Google Scholar 

  6. Pan W-H, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986;123:504–516.

    PubMed  CAS  Google Scholar 

  7. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95–108.

    PubMed  CAS  Google Scholar 

  8. O’Brien IA, O’Hare P, Corrall RJ. Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 1986;55:348–354.

    Article  PubMed  Google Scholar 

  9. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomie neuropathy. Br Med J 1982;295:916–918.

    Article  Google Scholar 

  10. Ewing DJ. Cardiac autonomie neuropathy. In Jarrett RJ, ed. Diabetes and Heart Disease. Elsevier, Amsterdam, 1984, pp. 99–132.

    Google Scholar 

  11. Toyry JP, Niskannen LK, Uusitupa MI, et al. Occurence, predictors and clinical significance of autonomic neuropathy in NIDDM. Diabetes 1996;45:308–315.

    Article  PubMed  CAS  Google Scholar 

  12. O’Brien IA, O’Hare JP, Lewin IG, Corrall RJ. The prevalence of autonomic neuropathy in insulindependent diabetes mellitus: a controlled study based on heart rate variability. Q J Med 1986;61:957–967.

    PubMed  Google Scholar 

  13. Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present and future. Diabetes 1995;44:1355–1361.

    Article  PubMed  CAS  Google Scholar 

  14. Barzilay J, Warram JH, Krolewski AS, et al. Risk of cardiovascular autonomie neuropathy is associated with the HLA-DR3/4 phenotype in type I diabetes mellitus. Ann Int Med 1992;116:544–549.

    PubMed  CAS  Google Scholar 

  15. Ewing DJ, Campbell IW, Clarke BF. Heart range changes in diabetes mellitus. Lancet 1981;1:183–186.

    Article  PubMed  CAS  Google Scholar 

  16. Langer A, Freeman MR, Josse RG, et al. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomie dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995;25:610–618.

    Article  PubMed  CAS  Google Scholar 

  17. Burgos LG, Ebert TJ, Assiddao C, et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomie neuropathy. Anesthesiology 1989;70:591–597.

    Article  PubMed  CAS  Google Scholar 

  18. Odemuyiwa O, Malik M, Farrell T, et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991;68:434–439.

    Article  PubMed  CAS  Google Scholar 

  19. Bellavere F, Balzani I, De Masi G, et al. Power spectral analysis of heart variation improves assessment of diabetic cardiac autonomie neuropathy. Diabetes 1992;41:633–640.

    Article  PubMed  CAS  Google Scholar 

  20. Malik M, Camm AJ. Components of heart rate variability: what they really mean and what we really measure. Am J Cardiol 1993;72:821,822.

    Article  PubMed  CAS  Google Scholar 

  21. Ziegler D. Diabetic cardiovascular autonomie neuropathy: prognosis, diagnosis and treatment. Diabetes /Metab Rev 1994;10:4339–4383.

    Google Scholar 

  22. Ewing DJ, Clarke BF. Diabetic autonomie neuropathy: present insights and future perspectives. Diabetes Care 1986;9:648–665.

    PubMed  CAS  Google Scholar 

  23. Pfeifer MA, Peterson H. Cardiovascular autonomie neuropathy. In: Dyck P, et al. ed. Diabetic Neuropathy. Saunders, Philadelphia, 1987, pp. 122–133.

    Google Scholar 

  24. Neubauer B, Christensen NJ. Norepinephrine, epinephrine, and dopamine contents of the cardiovascular system in long-term diabetics. Diabetes 1976;25:6–10.

    Article  PubMed  CAS  Google Scholar 

  25. Mantysaari M, Kuikka J, Mustonen J, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [I–123] metaiodobenzylguanidine. Diabetes 1992;41:1069–1075.

    Article  PubMed  CAS  Google Scholar 

  26. Allman KC, Stevens MJ, Wieland DM, et al. Noninvasive assessment of cardiac autonomie neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1993;22:1425–1432.

    Article  PubMed  CAS  Google Scholar 

  27. Savage MP, Krolewski AS, Kenien GG, Nunez R, Jadzinky M, Fox D, Rapaport M. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988;62:665–669.

    Article  PubMed  CAS  Google Scholar 

  28. Smith JW, Marcus FI, Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 1984;54:718–721.

    Article  PubMed  CAS  Google Scholar 

  29. Leor J, Nesto RW, Kloner RA. Acute myocardial infarction and diabetes mellitus [Commentary]. Cardiovasc Res 1993;27:1913–1915.

    Article  PubMed  CAS  Google Scholar 

  30. Faerman I, Faccio E, Milei J, et al. Autonomie neuropathy and painless myocardial infarction in diabetic patients: histologie evidence of their relationship. Diabetes 1977;6:1147–1158.

    Article  Google Scholar 

  31. Zarich S, Waxman S, Nesto RW, et al. Effect of autonomie nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol 1994;24:956–962.

    Article  PubMed  CAS  Google Scholar 

  32. Ambepityia G, Kopelman PG, Ingram D, et al. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomie function. J Am Coll Cardiol 1990;15:72–77.

    Article  PubMed  CAS  Google Scholar 

  33. Nesto RW, Watson FS, Kowalchuk GJ, et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dypiridamole thallium scintigraphy. Am Heart J 1990;120:1073–1077.

    Article  PubMed  CAS  Google Scholar 

  34. O’Sullivan JJ, Conroy RM, MacDonald K, et al. Silent ischaemia in diabetic men with autonomie neuropathy. Br Heart J 1991;66:313–315.

    Article  PubMed  Google Scholar 

  35. Marchant B, Umachandran V, Stevenson R, et al. Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993;22:1433–1437.

    Article  PubMed  CAS  Google Scholar 

  36. Barrett-Connor E, Orchard T. Insulin dependent diabetes mellitus and ischemic heart disease. Diabetes Care 1985;8:65–70.

    PubMed  Google Scholar 

  37. Savage MP, Krolewski A, Kemien G, et al. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988;62:665–669.

    Article  PubMed  CAS  Google Scholar 

  38. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992;20:736–744.

    Article  PubMed  CAS  Google Scholar 

  39. Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985;8:230–234.

    Article  PubMed  CAS  Google Scholar 

  40. Hands M, Rutherford J, Muller J. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurence, outcome and prognostic factors. J Am Coll Cardiol 1989;14:40–46.

    Article  PubMed  CAS  Google Scholar 

  41. Partamian JO, Bradley RF. Acute myocardial infarction in 258 cases of diabetes: immediate mortality and five year survival. N Engl J Med 1965;273:455–461.

    Article  PubMed  CAS  Google Scholar 

  42. Bierman E. Atherogenesis in diabetes. Atherosclerosis Thrombosis 1992; 12:647.

    Article  CAS  Google Scholar 

  43. Kwaan H. Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes. Diabetes 1992;41(S2):31.

    Google Scholar 

  44. Margolis JR, Kannel WB, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction — silent and symptomatic: eighteen year follow-up: the Framingham study. Am J Cardiol 1973;32:1–7.

    Article  PubMed  CAS  Google Scholar 

  45. Cabin HS, Roberts WC. Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized (“silent”) previous acute myocardial infarction. Am J Cardiol 1982;50:677–681.

    Article  PubMed  CAS  Google Scholar 

  46. Nesto RW, Phillips RT. Asymptomatic myocardial ischemia in diabetic patients. Am J Med 1986;80(S4C):40–47.

    Article  PubMed  CAS  Google Scholar 

  47. Jaffe AS, Spadaro J, Schectman K, et al. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984;108:1–7.

    Article  Google Scholar 

  48. Rubier S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595–602.

    Article  Google Scholar 

  49. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 1974;34:29–34.

    Article  PubMed  CAS  Google Scholar 

  50. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J 1989;118:1000–1012.

    Article  PubMed  CAS  Google Scholar 

  51. Kahn JK, Zola B, Juni JE, Vini AI. Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol 1986;7:1303–1309.

    Article  PubMed  CAS  Google Scholar 

  52. Airaksinen KEJ, Koistinen MJ, Ikaheimo MJ, et al. Augmentation of atrial contribution to left ventricular filling in IDDM subjects as assessed by Doppler echocardiography. Diabetes Care 1989;12:159–161.

    Article  PubMed  CAS  Google Scholar 

  53. Vered Z, Battler A, Segal P, et al. Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus. Am J Cardiol 1984;54:633–637.

    Article  PubMed  CAS  Google Scholar 

  54. Kienzle MG, Ferguson DW, Birkett CL, et al. Clinical hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992;69:482–485.

    Article  Google Scholar 

  55. Nesto RW, Zarich SW, Jacoby RM, Kamalesh M. Heart disease in diabetes, In: Kahn RC, Weir GC, eds. Joslin’s Diabetes. Lea & Febiger, Malvern, PA, 1994, pp. 836–851.

    Google Scholar 

  56. Hilsted J, Richter E, Madsbad S, et al. Metabolie and cardiovascular responses to epinephrine in diabetic autonomie neuropathy. N Engl J Med 1987;317:421–426.

    Article  PubMed  CAS  Google Scholar 

  57. Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomie neuropathy. J Clin Endocrinol Metab 1987;64:751–754.

    Article  PubMed  CAS  Google Scholar 

  58. Ong JJ, Sarma JS, Venkataraman K, Levin SR. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomie neuropathy: implications for the mechanism of sudden death. Am Heart J 1993;125:744–752.

    Article  PubMed  CAS  Google Scholar 

  59. Bravenboer B, Hendricksen P-H, Oey LP, et al. Is the corrected QT interval a reliable indicator of the severity of diabetic autonomie neuropathy? Diabetes Care 1993;16:1249–1253.

    Article  PubMed  CAS  Google Scholar 

  60. ISIS-2 Collaborative Group. Randomized trial of intravenous Streptokinase, oral aspirin, both or neither among 17,817 cases of suspected acute myocardial infarction. Lancet 1988;2:349–360.

    Google Scholar 

  61. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043–1065.

    Article  Google Scholar 

  62. Kleiger RE, Miller JP, Bigger JT, Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256–262.

    Article  PubMed  CAS  Google Scholar 

  63. Pagani M, Malfatto G, Pierini S, et al. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst 1988;23:143–153.

    Article  PubMed  CAS  Google Scholar 

  64. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoetin. N Engl J Med 1993;329:611–615.

    Article  PubMed  CAS  Google Scholar 

  65. Hoeltdke RD, Davis KM, Joseph J, et al. Hemodynamic effects of octreotide in patients with autonomic neuropathy. Circulation 1991;84:168–176.

    Article  Google Scholar 

  66. The Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.

    Article  Google Scholar 

  67. Vanninen E, Uusitupa M, Lansimie E, et al. Effect of metabolic control on autonomie function in obese patients with newly diagnosed type 2 diabetes. Diabetic Med 1996;10:66–73.

    Article  Google Scholar 

  68. van Ravenswaaij-Arts CM, Kolee LA, Hopman JC, et al. Heart rate variability. Ann Intern Med 1993;118:436–447.

    PubMed  Google Scholar 

  69. Zuanetti G, Latini R, Neilson JM, Antiarrhythmic Drug Evaluation Group (ADEG). Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. J Am Coll Cardiol 1991;17:604–612.

    Article  PubMed  CAS  Google Scholar 

  70. O’Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80:234–244.

    Article  PubMed  Google Scholar 

  71. Hull SS, Vanoli E, Adamson PB, et al. Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation 1994;89:548–552.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Efthymios N. Deliargyris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard W. Nesto MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

    Aristidis Veves MD

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Deliargyris, E.N., Nesto, R.W. (1998). Autonomic Neuropathy and Heart Disease. In: Veves, A. (eds) Clinical Management of Diabetic Neuropathy. Contemporary Endocrinology, vol 7. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1816-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1816-6_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-7296-0

  • Online ISBN: 978-1-4612-1816-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation